This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignees: Catalym Gmbh, Julius-Maximilians-Universitat Wurzburg. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 1 
1 out of 54 
Years Active: 2025
Title: Manfred Rüdiger: Innovator in Cancer Treatment
Introduction
Manfred Rüdiger is a notable inventor based in Planegg, Germany. He has made significant contributions to the field of cancer treatment through his innovative research and development.
Latest Patents
Rüdiger holds a patent for an "Anti-GDF15 Antibody and a Dosage Regimen for the Treatment of Cancer." This patent represents a crucial advancement in therapeutic options for cancer patients, showcasing his commitment to improving healthcare outcomes.
Career Highlights
Throughout his career, Rüdiger has worked with prestigious institutions, including Julius-Maximilians-Universität Würzburg and Catalym GmbH. His experience in these organizations has allowed him to develop and refine his innovative ideas in the medical field.
Collaborations
Rüdiger has collaborated with esteemed colleagues such as Eugen Leo and Markus Haake. These partnerships have further enhanced his research and contributed to the success of his projects.
Conclusion
Manfred Rüdiger's work in developing cancer treatment solutions exemplifies the impact of innovation in medicine. His contributions continue to inspire advancements in the field and offer hope to many patients.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile